What is Hepatitis B? - Hepatitis Central | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Hepatitis B

Hepatitis B Information

Hepatitis B

Hepatitis B FAQ’s

Hepatitis B Fact Sheet

Chronic Hepatitis B

Facts for the Hepatitis B Carrier

What are the clinical consequences of acute HBV infection?

Vaccination of Patients With Liver Disease: Who, When, and How


Hepatitis B with Fulminant Hepatitis

Medical Fundamentals of Hepatitis A & B

Persistence of antibody to Hepatitis B surface antigen

Autoantibodies Present in Chronic Hepatitis C and Chronic Hepatitis B Viral Infections

Transmission of Hepatitis B to patients from four infected surgeons without Hepatitis B e antigen. The Incident Investigation Teams and others.

Molecular Basis for Persistent Hepatitis B Virus Infection In the Liver After Clearance of Serum Hepatitis B Surface Antigen

Hepatitis B Breaking the Cycle

Hepatitis B Information and Support List


Hepatitis B Treatment

Drug Aids in Hepatitis B Cirrhosis

Zeffix May Offer Long-Term Benefits For Chronic Hepatitis B Patients

Lamivudine Significantly Alleviates Liver Disease In Patients With Chronic Hepatitis B

FDA Panel Backs Hepatitis B Pills

Hepatitis B & Therapy with Interferon

Diet & Chronic Liver Disease

NZ first in line for hepatitis pill

European CPMP Gives Positive Opinion on Zeffix (lamivudine) for Treatment of Chronic Hepatitis B

Schering-Plough Receives U.S. Marketing Approval for INTRON(R) A Pediatric Use in Chronic Hepatitis B

Antisense RNA Complementary to Hepatitis B Virus Specifically Inhibits Viral Replication

HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China

Prophylaxis against Hepatitis B recurrence following liver transplantation using combination

Genzyme Transgenics, Interferon Sciences to Collaborate on Development of Transgenic Interferon Alpha

Biochem Pharma’s Discovery Epivir(R)-HBVT (Lamivudine) Recommended For Approval By U.S. FDA Advisory Committee For The Treatment of Chronic Hepatitis B



Chronic Carriers of Hepatitis B Virus Who Clear Hepatitis B Surface Antigen: Are They Really “Off the Hook”?

Vaccination of Patients With Liver Disease: Who, When, and How Vaccination of Patients With Liver Disease: Who, When, and How


Don’t forget to search through our Research & Treatment News for more Hepatitis B news and information.